Literature DB >> 16424022

Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: role in epithelial-mesenchymal transition.

Hiroyuki Yoshida1, Russell Broaddus, Wenjun Cheng, SuSu Xie, Honami Naora.   

Abstract

Homeobox genes encode transcription factors that control cell differentiation and play essential roles in developmental patterning. Increasing evidence indicates that many homeobox genes are aberrantly expressed in cancers, and that their deregulation significantly contributes to tumor progression. The homeobox gene HOXA10 controls uterine organogenesis during embryonic development and functional endometrial differentiation in the adult. We investigated whether HOXA10 expression is deregulated in endometrial carcinomas, and how counteracting this aberrant expression modifies tumor behavior. We found that down-regulation of HOXA10 expression in endometrial carcinomas strongly correlates with increased tumor grade and is associated with methylation of the HOXA10 promoter. Enforced expression of HOXA10 in endometrial carcinoma cells inhibited invasive behavior in vitro and tumor dissemination in nude mice. The inhibitory effect of HOXA10 on invasive behavior was attributable at least in part to the ability of HOXA10 to induce expression of the epithelial cell adhesion molecule E-cadherin by down-regulating expression of Snail, a repressor of E-cadherin gene transcription. These findings reveal a novel role for HOXA10 deregulation in the progression of endometrial carcinoma by promoting epithelial-mesenchymal transition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424022     DOI: 10.1158/0008-5472.CAN-05-2828

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  Metabolic programming, epigenetics, and gestational diabetes mellitus.

Authors:  Sara E Pinney; Rebecca A Simmons
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

2.  MicroRNA-544a Regulates Migration and Invasion in Colorectal Cancer Cells via Regulation of Homeobox A10.

Authors:  Shangfeng Sun; Changying Su; Yunxiao Zhu; Haiyan Li; Ning Liu; Tong Xu; Chao Sun; Yanfeng Lv
Journal:  Dig Dis Sci       Date:  2016-05-10       Impact factor: 3.199

3.  Homeobox Gene Deregulation: Impact on the Hallmarks of Cancer.

Authors:  Dhwani Haria; Honami Naora
Journal:  Cancer Hallm       Date:  2013-09-01

Review 4.  Epigenetic control of embryo-uterine crosstalk at peri-implantation.

Authors:  Shuangbo Kong; Chan Zhou; Haili Bao; Zhangli Ni; Mengying Liu; Bo He; Lin Huang; Yang Sun; Haibin Wang; Jinhua Lu
Journal:  Cell Mol Life Sci       Date:  2019-07-27       Impact factor: 9.261

5.  Novel Epigenetic Biomarkers Mediating Bisphenol A Exposure and Metabolic Phenotypes in Female Mice.

Authors:  Olivia S Anderson; Jung H Kim; Karen E Peterson; Brisa N Sanchez; Karilyn E Sant; Maureen A Sartor; Caren Weinhouse; Dana C Dolinoy
Journal:  Endocrinology       Date:  2017-01-01       Impact factor: 4.736

6.  Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming.

Authors:  Jason G Bromer; Jie Wu; Yuping Zhou; Hugh S Taylor
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

7.  Global analysis of genes regulated by HOXA10 in decidualization reveals a role in cell proliferation.

Authors:  Z Lu; J Hardt; J J Kim
Journal:  Mol Hum Reprod       Date:  2008-05-02       Impact factor: 4.025

8.  A homeobox gene related to Drosophila distal-less promotes ovarian tumorigenicity by inducing expression of vascular endothelial growth factor and fibroblast growth factor-2.

Authors:  Fumikata Hara; Shaija Samuel; Jinsong Liu; Daniel Rosen; Robert R Langley; Honami Naora
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 9.  Epigenetic mechanisms in the development of type 2 diabetes.

Authors:  Sara E Pinney; Rebecca A Simmons
Journal:  Trends Endocrinol Metab       Date:  2009-10-26       Impact factor: 12.015

10.  S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling.

Authors:  Ran Xie; Matthew P Schlumbrecht; Gregory L Shipley; Susu Xie; Roland L Bassett; Russell R Broaddus
Journal:  Lab Invest       Date:  2009-06-08       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.